Ligand validation:4LK7

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 4LK7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LK7_GAL_C_203	80%	22%	0.075	0.939	2.3	0.95	2	1	0	0	92%	0.9167
4LK7_GAL_A_203	71%	24%	0.092	0.926	2.29	0.84	2	1	0	0	92%	0.9167
4LK7_GAL_B_203	66%	24%	0.094	0.913	2.35	0.81	3	1	0	0	92%	0.9167
4LK7_GAL_D_203	64%	20%	0.104	0.917	2.49	0.97	2	-	0	0	92%	0.9167
4YW7_GAL_B_202	96%	66%	0.066	0.976	0.57	0.74	-	-	0	0	100%	1
1OKO_GAL_D_902	96%	56%	0.065	0.972	0.9	0.82	-	1	0	0	100%	0.6
4CP9_GAL_A_1123	92%	25%	0.058	0.962	1.3	1.72	1	6	0	0	92%	0.9167
4LKF_GAL_A_201	91%	55%	0.083	0.984	0.92	0.83	-	-	0	0	92%	0.9167
4LJH_GAL_A_203	85%	25%	0.065	0.946	2.36	0.74	2	-	0	0	92%	0.9167
4WWH_GAL_A_401	100%	64%	0.026	0.99	0.47	0.9	-	-	0	0	100%	1
5ELB_GAL_C_202	100%	58%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
5DVJ_GAL_B_501	98%	40%	0.047	0.968	0.95	1.38	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.